Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1971 Nov;22(5):870–875. doi: 10.1128/am.22.5.870-875.1971

Susceptibility of Recent Isolates of Pseudomonas aeruginosa to Gentamicin, Polymyxin, and Five Penicillins, with Observations on the Pyocin and Immunotypes of the Strains 1

Jonathan L Adler 1,2,3, Maxwell Finland 1,2,3
PMCID: PMC376437  PMID: 4332044

Abstract

The susceptibilities of recently isolated strains of Pseudomonas aeruginosa to gentamicin, polymyxin B, carbenicillin, ampicillin, penicillin G, and two newer penicillins were tested with the inocula-replicating technique by using undiluted and 10−3 dilutions of the cultures. With either inoculum, polymyxin B was the most active agent, and a comparison with previous data from this laboratory showed that the susceptibility of P. aeruginosa to this antibiotic had not changed over the past 20 years. Gentamicin was nearly as active as polymyxin, all but 2 of the 141 strains tested with the diluted inoculum being inhibited by 6.25 μg/ml or less. AB-2288, an agent resembling carbenicillin, was four times more active than carbenicillin or BLP-1654; the last two were equally active against the 10−3 inoculum. A more marked inoculum effect was noted with the penicillin analogues tested, the increase in minimum inhibiting concentration with the undiluted culture being eight-fold for carbenicillin and at least 16-fold for AB-2288 and BLP-1654. Pyocin typing and serotyping failed to demonstrate any clearly predominating types.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler J. L., Burke J. P., Finland M. Infection and antibiotic usage at Boston City Hospital, January 1970. Arch Intern Med. 1971 Mar;127(3):460–465. [PubMed] [Google Scholar]
  2. EICKHOFF T. C., FINLAND M. POLYMYXIN B AND COLISTIN: IN VITRO ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA. Am J Med Sci. 1965 Feb;249:172–174. [PubMed] [Google Scholar]
  3. FINLAND M., JONES W. F., Jr, BARNES M. W. Occurrence of serious bacterial infections since introduction of antibacterial agents. J Am Med Assoc. 1959 Aug 29;170:2188–2197. doi: 10.1001/jama.1959.63010180008012. [DOI] [PubMed] [Google Scholar]
  4. FRANK P. F., WILCOX C., FINLAND M. In vitro sensitivity of Bacillus proteus and Pseudomonas aeruginosa to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin. J Lab Clin Med. 1950 Feb;35(2):205–214. [PubMed] [Google Scholar]
  5. Fierer J., Taylor P. M., Gezon H. M. Pseudomonas aeruginosa epidemic traced to delivery-room resuscitators. N Engl J Med. 1967 May 4;276(18):991–996. doi: 10.1056/NEJM196705042761801. [DOI] [PubMed] [Google Scholar]
  6. Fisher M. W., Devlin H. B., Gnabasik F. J. New immunotype schema for Pseudomonas aeruginosa based on protective antigens. J Bacteriol. 1969 May;98(2):835–836. doi: 10.1128/jb.98.2.835-836.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gillies R. R., Govan J. R. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol. 1966 Apr;91(2):339–345. doi: 10.1002/path.1700910207. [DOI] [PubMed] [Google Scholar]
  8. Govan J. R., Gillies R. R. Further studies in the pyocine typing of Pseudomonas pyocyanea. J Med Microbiol. 1969 Feb;2(1):17–25. doi: 10.1099/00222615-2-1-17. [DOI] [PubMed] [Google Scholar]
  9. Hanessian S., Regan W., Watson D., Haskell T. H. Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine. Nat New Biol. 1971 Feb 17;229(7):209–210. doi: 10.1038/newbio229209a0. [DOI] [PubMed] [Google Scholar]
  10. KLEIN J. O., EICKHOFF T. C., FINLAND M. GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS. Am J Med Sci. 1964 Nov;248:528–544. [PubMed] [Google Scholar]
  11. KUNIN C. M., WILCOX C., NAJARIAN A., FINLAND M. Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin. Proc Soc Exp Biol Med. 1958 Nov;99(2):312–316. doi: 10.3181/00379727-99-24334. [DOI] [PubMed] [Google Scholar]
  12. Koch-Weser J., Sidel V. W., Federman E. B., Kanarek P., Finer D. C., Eaton A. E. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970 Jun;72(6):857–868. doi: 10.7326/0003-4819-72-6-857. [DOI] [PubMed] [Google Scholar]
  13. POSTIC B., FINLAND M. In vitro susceptibility of recently isolated strains of Pseudomonas aeruginosa to ten antibiotics. Am J Med Sci. 1961 Nov;242:551–559. doi: 10.1097/00000441-196111000-00004. [DOI] [PubMed] [Google Scholar]
  14. POSTIC B., FINLAND M. Observations on bacteriophage typing of Pseudomonas aeruginosa. J Clin Invest. 1961 Nov;40:2064–2075. doi: 10.1172/JCI104432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SABATH L. D., ABRAHAM E. P. SYNERGISTIC ACTION OF PENICILLINS AND CEPHALOSPORINS AGAINST PSEUDOMONAS PYOCYANEA. Nature. 1964 Dec 12;204:1066–1069. doi: 10.1038/2041066a0. [DOI] [PubMed] [Google Scholar]
  16. Sabath L. D., Jago M., Abraham E. P. Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea. Biochem J. 1965 Sep;96(3):739–752. doi: 10.1042/bj0960739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sabath L. D., McCall C. E., Steigbigel N. H., Finland M. Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) 1966;6:149–155. [PubMed] [Google Scholar]
  18. Smith C. B., Dans P. E., Wilfert J. N., Finland M. Use of gentamicin in combinations with other antibiotics. J Infect Dis. 1969 Apr-May;119(4):370–377. doi: 10.1093/infdis/119.4-5.370. [DOI] [PubMed] [Google Scholar]
  19. Smith C. B., Finland M. Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol. 1968 Nov;16(11):1753–1760. doi: 10.1128/am.16.11.1753-1760.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Steigbigel N. H., McCall C. E., Reed C. W., Finland M. Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci. 1967 Sep 27;145(2):224–236. doi: 10.1111/j.1749-6632.1967.tb50221.x. [DOI] [PubMed] [Google Scholar]
  21. Steigbigel N. H., Reed C. W., Finland M. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci. 1968 Mar;255:179–195. doi: 10.1097/00000441-196803000-00005. [DOI] [PubMed] [Google Scholar]
  22. WRIGHT S. S., POTEE K. G., FINLAND M. Susceptibility of Pseudomonas to ten antibiotics in vitro: some properties of recently isolated strains. Am J Clin Pathol. 1954 Oct;24(10):1121–1132. doi: 10.1093/ajcp/24.10.1121. [DOI] [PubMed] [Google Scholar]
  23. WRIGHT W. W., WELCH H. Chemical, biological and clinical observations on colistin. Antibiot Annu. 1959;7:61–74. [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES